Unknown

Dataset Information

0

PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis.


ABSTRACT: Colorectal cancer (CRC) is a major cause of human death. Mortality is primarily due to metastatic organ colonization, with the liver being the main organ affected. We modeled metastatic CRC (mCRC) liver colonization using patient-derived primary and metastatic tumor xenografts (PDX). Such PDX modeling predicted patient survival outcomes. In vivo selection of multiple PDXs for enhanced metastatic colonization capacity upregulated the gluconeogenic enzyme PCK1, which enhanced liver metastatic growth by driving pyrimidine nucleotide biosynthesis under hypoxia. Consistently, highly metastatic tumors upregulated multiple pyrimidine biosynthesis intermediary metabolites. Therapeutic inhibition of the pyrimidine biosynthetic enzyme DHODH with leflunomide substantially impaired CRC liver metastatic colonization and hypoxic growth. Our findings provide a potential mechanistic basis for the epidemiologic association of anti-gluconeogenic drugs with improved CRC metastasis outcomes, reveal the exploitation of a gluconeogenesis enzyme for pyrimidine biosynthesis under hypoxia, and implicate DHODH and PCK1 as metabolic therapeutic targets in CRC metastatic progression.

SUBMITTER: Yamaguchi N 

PROVIDER: S-EPMC7299340 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis.

Yamaguchi Norihiro N   Weinberg Ethan M EM   Nguyen Alexander A   Liberti Maria V MV   Goodarzi Hani H   Janjigian Yelena Y YY   Paty Philip B PB   Saltz Leonard B LB   Kingham T Peter TP   Loo Jia Min JM   de Stanchina Elisa E   Tavazoie Sohail F SF  

eLife 20191216


Colorectal cancer (CRC) is a major cause of human death. Mortality is primarily due to metastatic organ colonization, with the liver being the main organ affected. We modeled metastatic CRC (mCRC) liver colonization using patient-derived primary and metastatic tumor xenografts (PDX). Such PDX modeling predicted patient survival outcomes. In vivo selection of multiple PDXs for enhanced metastatic colonization capacity upregulated the gluconeogenic enzyme PCK1, which enhanced liver metastatic grow  ...[more]

Similar Datasets

| S-EPMC10824957 | biostudies-literature
| S-EPMC3772859 | biostudies-literature
| S-EPMC9446818 | biostudies-literature
2019-11-30 | GSE125404 | GEO
| S-EPMC4731165 | biostudies-literature
| S-EPMC7427987 | biostudies-literature
| S-EPMC6153585 | biostudies-literature
| S-EPMC10002472 | biostudies-literature
| S-EPMC11364717 | biostudies-literature
| S-EPMC6274963 | biostudies-literature